TipHub

₹2,480

▲ +42.17 +1.73%

As of 22 Sept 2026 · delayed

NSE Listed

Mankind Pharma Limited (MANKIND)

Volume: 6,67,073Avg Vol 1W: 7,26,642.8Avg Vol 1M: 4,03,426.8552W Range:₹1,909.7₹2,674
NSE BSE www.mankindpharma.com AI Report
Key Ratios
Checked 8h ago
Market Cap₹1,02,435 Cr
Current Price₹2,480
Previous Close₹2,437.83
High / Low (52w)₹2,674 / ₹1,909.7
Volume6,67,073
Avg Vol (1W)7,26,642.8
Avg Vol (1M)4,03,426.85
Stock P/E48.02
Book Value₹394.64
Dividend Yield4%
ROE11.74%
ROA7.36%
Revenue (TTM)₹14,636 Cr
Revenue Growth19%
Profit Margin13.86%
Total Debt₹5,526 Cr
Shares Outstanding41 Cr
Face Value₹1
EPS (TTM)₹51.65
P/B6.28
Debt / Equity0.48
50 DMA₹2,424.04
200 DMA₹2,292.22
Day change+1.73%
Price Chart
₹2,480▼ 4.43% · 1Y
₹2618₹192740.9L
2025-09-22
2026-09-22

20-day avg volume: 4.0L shares

Pros
  • Pays a dividend yield of 4.0%.
  • Company is almost debt-free.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹3,061 Cr₹3,199 Cr₹3,079 Cr₹3,570 Cr₹3,697 Cr₹3,567 Cr₹3,443 Cr₹4,031 Cr
EBITDA₹856 Cr₹706 Cr₹704 Cr₹708 Cr₹791 Cr₹770 Cr₹821 Cr₹875 Cr
Net Profit₹653 Cr₹380 Cr₹421 Cr₹438 Cr₹512 Cr₹409 Cr₹554 Cr₹568 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹2,119 Cr₹12,744 Cr₹2,570 Cr₹2,609 Cr₹2,633 Cr₹14,636 Cr₹2,582 Cr₹2,964 Cr
EBITDA₹447 Cr₹2,934 Cr₹646 Cr₹672 Cr₹727 Cr₹3,090 Cr₹936 Cr₹852 Cr
Net Profit₹238 Cr₹1,991 Cr₹415 Cr₹459 Cr₹449 Cr₹1,913 Cr₹714 Cr₹558 Cr
EPS—49.19———46.28——
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹5,073 Cr₹6,373 Cr₹9,148 Cr₹9,715 Cr₹11,963 Cr₹27,760 Cr₹28,080 Cr
Total Liabilities₹1,402 Cr₹1,510 Cr₹2,831 Cr₹2,092 Cr₹2,387 Cr₹13,191 Cr₹11,518 Cr
Equity₹3,672 Cr₹4,863 Cr₹6,316 Cr₹7,623 Cr₹9,576 Cr₹14,568 Cr₹16,561 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹1,401 Cr₹1,591 Cr₹1,419 Cr₹2,136 Cr₹2,594 Cr₹2,980 Cr₹3,714 Cr
Investing₹-439 Cr₹-1,222 Cr₹-1,369 Cr₹-1,054 Cr₹-2,082 Cr₹-12,683 Cr₹-196 Cr
Financing₹-531 Cr₹-8 Cr₹605 Cr₹-740 Cr₹5 Cr₹10,233 Cr₹-2,953 Cr
Free Cash Flow₹1,401 Cr₹1,591 Cr₹1,419 Cr₹2,136 Cr₹2,594 Cr₹2,980 Cr₹3,714 Cr
Shareholding
Promoter 72.63% Institutions 24.84% Public 2.53%
Efficiency & Working Capital
ROCE13.1%
Interest Coverage4.6
Dividend Payout—
Debtor Days44 d
Inventory Days55 d
Payable Days34 d
Cash Conversion Cycle65 d
Working Capital Days99 d
Shareholding Details

As of 2026-06-30

Promoter72.6%
FII9.5%
DII15.4%
Institutions24.8%
Public2.5%
Promoter Pledge0%
No. of Shareholders1,66,715
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters76.5%76.5%74.9%74.9%74.9%72.7%72.7%72.7%72.7%72.7%72.7%72.6%
FIIs4.2%6.7%9.9%11.6%12.4%13.3%12.9%13.1%12.8%11.3%10.2%9.5%
DIIs4.4%9.5%11.1%9.9%9.9%11.1%11.5%11.5%11.9%13.2%14.5%15.4%
Public14.9%7.3%4.1%3.6%2.9%2.9%2.9%2.7%2.6%2.7%2.6%2.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,34,7311,27,4491,35,1161,53,4501,63,8541,71,2811,80,5971,79,5491,70,3471,77,5391,77,6061,66,715
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Ramesh Juneja Family Trust (held In The Name Of Ramesh Juneja, Managing Trustee)Shareholding of Promoter and Promoter Group20.2%8.34 Cr
Rajeev Juneja Family Trust (held In The Name Of Rajeev Juneja, Managing Trustee)Shareholding of Promoter and Promoter Group19.4%7.99 Cr
Prem Sheetal Family Trust (held In The Name Of Arora Family Private Limited, Trustee)Shareholding of Promoter and Promoter Group15%6.18 Cr
Sheetal AroraShareholding of Promoter and Promoter Group4.7%1.93 Cr
Puja JunejaShareholding of Promoter and Promoter Group2.8%1.15 Cr
Nps Trust - A/c Sbi Pension Fund Scheme - CorporatPublic Shareholding2.8%1.14 Cr
Poonam JunejaShareholding of Promoter and Promoter Group2.6%1.06 Cr
Nippon Life India Trustee Ltd-a/c Nippon India NifPublic Shareholding2.1%85,47,299
Arjun JunejaShareholding of Promoter and Promoter Group2%81,54,463
Ramesh JunejaShareholding of Promoter and Promoter Group1.7%68,55,990
Rajeev JunejaShareholding of Promoter and Promoter Group1.6%65,00,021
Sbi Arbitrage Opportunities FundPublic Shareholding1.6%64,26,527
Government Pension Fund GlobalPublic Shareholding1.3%53,22,821
Eklavya JunejaShareholding of Promoter and Promoter Group0.9%38,96,788
Chanakya JunejaShareholding of Promoter and Promoter Group0.9%38,96,788
Mishka AroraShareholding of Promoter and Promoter Group0.7%29,55,692
Ria Chopra JunejaShareholding of Promoter and Promoter Group0.3%12,92,884
Ayushi Juneja SikriShareholding of Promoter and Promoter Group0%0
Pushpa Rani AggarwalShareholding of Promoter and Promoter Group0%0
Rajeev Mohan AgarwalShareholding of Promoter and Promoter Group0%0
Geeta AgarwalShareholding of Promoter and Promoter Group0%0
Ashok KumarShareholding of Promoter and Promoter Group0%0
Asha MadanShareholding of Promoter and Promoter Group0%0
Sanjay MadanShareholding of Promoter and Promoter Group0%0
Gautam MadanShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
RAMESH CHAND JUNEJAChairman/ED & CEO2026
RAJEEV JUNEJAVice Chairman & M.D.2026
SHEETAL ARORAED / WTD / CEO / Promoter2026
SATISH KUMAR SHARMAE D & Wholetime Director2026
TILOKCHAND PUNAMCHAND OSTWALIndependent Non Exe. Director2026
VIJAYA SAMPATHIndependent Non Exe. Director2026
Vivek KalraIndependent Non Exe. Director2026
Hitesh Kumar JainCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceutical & Other Related Prod₹3,877 Cr100%
Segments — Geography
RegionRevenueShare
Within India₹9,435 Cr90.5%
Outside India₹985 Cr9.5%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹12284141
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-30Board Meetings—
dividend2025-08-08₹1 (100%)Interim
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202653,601313259723454,428
20261,3290140181,361
202651,271298245721652,050
Insider / Designated-Person Trades

3 recent disclosure(s)

Puja JunejaDisposal · 22,71,336
Arjun JunejaDisposal · 24,01,128
Sheetal AroraDisposal · 18,17,070
Substantial Acquisitions (SAST)

2 disclosure(s)

—20/12/2024 · —
Market12/12/2023 · 1,80,00,000
Company Information
Incorporated1991
ChairmanRAMESH CHAND JUNEJA
AuditorS R Batliboi & Co LLP/Bhagi Bhardwaj Gaur & Co
Investor Email[email protected]
🌐 www.mankindpharma.com ↗

📍 208 Okhla Industrial Estate, Phase-III, New Delhi, New Delhi, 110020

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Mangalam Cement Ltd.Manika Plastech LimitedManilam Industries Ind LimitedMan Industries (India) Ltd.Man Infraconstruction Ltd.Manipal Health Enterpri LimitedManomay Tex India Ltd.Manorama Industries Ltd.Mangalam Organics LimitedManugraphVedant Fashions LimitedCE Info Systems LimitedAll “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search